94 related articles for article (PubMed ID: 21344395)
1. Bone matrix regulates osteoclast differentiation and annexin A8 gene expression.
Crotti TN; O'Sullivan RP; Shen Z; Flannery MR; Fajardo RJ; Ross FP; Goldring SR; McHugh KP
J Cell Physiol; 2011 Dec; 226(12):3413-21. PubMed ID: 21344395
[TBL] [Abstract][Full Text] [Related]
2. Expression profile of RhoGTPases and RhoGEFs during RANKL-stimulated osteoclastogenesis: identification of essential genes in osteoclasts.
Brazier H; Stephens S; Ory S; Fort P; Morrison N; Blangy A
J Bone Miner Res; 2006 Sep; 21(9):1387-98. PubMed ID: 16939397
[TBL] [Abstract][Full Text] [Related]
3. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
4. Involvement of annexin A8 in the properties of pancreatic cancer.
Hata H; Tatemichi M; Nakadate T
Mol Carcinog; 2014 Mar; 53(3):181-91. PubMed ID: 23001853
[TBL] [Abstract][Full Text] [Related]
5. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
[TBL] [Abstract][Full Text] [Related]
6. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
Merle B; Itzstein C; Delmas PD; Chenu C
J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
[TBL] [Abstract][Full Text] [Related]
7. Effects of cell culture time and bone matrix exposure on calmodulin content and ATP-dependent cell membrane acid transport in avian osteoclasts and macrophages.
Williams JP; Dong SS; Whitaker CH; Jordan SE; Blair HC
J Cell Physiol; 1996 Dec; 169(3):411-9. PubMed ID: 8952690
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
Takeshita S; Kaji K; Kudo A
J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
[TBL] [Abstract][Full Text] [Related]
9. Tropomyosin isoforms localize to distinct microfilament populations in osteoclasts.
McMichael BK; Kotadiya P; Singh T; Holliday LS; Lee BS
Bone; 2006 Oct; 39(4):694-705. PubMed ID: 16765662
[TBL] [Abstract][Full Text] [Related]
10. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
Stein T; Price KN; Morris JS; Heath VJ; Ferrier RK; Bell AK; Pringle MA; Villadsen R; Petersen OW; Sauter G; Bryson G; Mallon EA; Gusterson BA
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6872-9. PubMed ID: 16203777
[TBL] [Abstract][Full Text] [Related]
11. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts.
Tachi K; Takami M; Zhao B; Mochizuki A; Yamada A; Miyamoto Y; Inoue T; Baba K; Kamijo R
Cell Tissue Res; 2010 Nov; 342(2):213-20. PubMed ID: 20941510
[TBL] [Abstract][Full Text] [Related]
13. Osteoclast differentiation induced by synthetic octacalcium phosphate through receptor activator of NF-kappaB ligand expression in osteoblasts.
Takami M; Mochizuki A; Yamada A; Tachi K; Zhao B; Miyamoto Y; Anada T; Honda Y; Inoue T; Nakamura M; Suzuki O; Kamijo R
Tissue Eng Part A; 2009 Dec; 15(12):3991-4000. PubMed ID: 19594360
[TBL] [Abstract][Full Text] [Related]
14. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
15. Relaxin stimulates osteoclast differentiation and activation.
Ferlin A; Pepe A; Facciolli A; Gianesello L; Foresta C
Bone; 2010 Feb; 46(2):504-13. PubMed ID: 19833242
[TBL] [Abstract][Full Text] [Related]
16. Expression of colony-stimulating factor-1 in vivo during the formation of osteoclasts.
Halasy-Nagy J; Hofstetter W
J Bone Miner Res; 1998 Aug; 13(8):1267-74. PubMed ID: 9718195
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human osteoclast differentiation by thioredoxin binding protein-2 and redox-sensitive signaling.
Aitken CJ; Hodge JM; Nishinaka Y; Vaughan T; Yodoi J; Day CJ; Morrison NA; Nicholson GC
J Bone Miner Res; 2004 Dec; 19(12):2057-64. PubMed ID: 15537450
[TBL] [Abstract][Full Text] [Related]
18. Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling.
Koide M; Kinugawa S; Ninomiya T; Mizoguchi T; Yamashita T; Maeda K; Yasuda H; Kobayashi Y; Nakamura H; Takahashi N; Udagawa N
J Bone Miner Res; 2009 Aug; 24(8):1469-80. PubMed ID: 19292614
[TBL] [Abstract][Full Text] [Related]
19. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
Ishida M; Amano S
J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
[TBL] [Abstract][Full Text] [Related]
20. Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation.
Hiruma Y; Hirai T; Tsuda E
Biochem Biophys Res Commun; 2011 Jun; 409(3):424-9. PubMed ID: 21586272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]